The reference to BP in our posts is not to one entity and it is...

The reference to BP in our posts is not to one entity and it is well understood that BP is not one. The reference is made in a generic sense of the many competing Big Pharma entities as BP, rather than spelling that out in each reference to BP. Please have a look at the exchange in that context. It does make sense that IMU can remain as one enterprise licensing out to various competing companies for regional control much like a master franchise arrangement. Clearly it still remains that a takeover is an option in the making, but that won’t stop IMU from pursuing its possible goals.